Methylene Chloride; Revision to Toxic Substances Control Act (TSCA) Risk Determination; Notice of Availability, 67901-67907 [2022-24533]
Download as PDF
Federal Register / Vol. 87, No. 217 / Thursday, November 10, 2022 / Notices
is placed in the official public docket
and made available in EPA’s electronic
public docket. If EPA cannot read your
comment due to technical difficulties
and cannot contact you for clarification,
EPA may not be able to consider your
comment.
Use of the https://
www.regulations.gov website to submit
comments to EPA electronically is
EPA’s preferred method for receiving
comments. The electronic public docket
system is an ‘‘anonymous access’’
system, which means EPA will not
know your identity, email address, or
other contact information unless you
provide it in the body of your comment.
Please ensure that your comments are
submitted within the specified comment
period. Comments received after the
close of the comment period will be
marked ‘‘late.’’ EPA is not required to
consider these late comments.
Amended Notice
EIS No. 20220139, Draft Supplement,
USCG, MARAD, TX, Texas Gulflink
Deepwater Port License Application,
Comment Period Ends: 11/30/2022,
Contact: Patrick Clark 202–372–1358.
Revision to FR Notice Published 09/
30/2022; Extending the Comment Period
from 11/14/2022 to 11/30/2022.
Steven Neugeboren,
Associate General Counsel.
Dated: November 4, 2022.
Cindy S. Barger,
Director, NEPA Compliance Division, Office
of Federal Activities.
[FR Doc. 2022–24502 Filed 11–9–22; 8:45 am]
[FR Doc. 2022–24552 Filed 11–9–22; 8:45 am]
BILLING CODE 6560–50–P
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
ENVIRONMENTAL PROTECTION
AGENCY
[FRL OP–OFA–043]
[EPA–HQ–OPPT–2016–0742; FRL–9946–02–
OCSPP]
Environmental Impact Statements;
Notice of Availability
Responsible Agency: Office of Federal
Activities, General Information 202–
564–5632 or https://www.epa.gov/nepa.
Weekly receipt of Environmental Impact
Statements (EIS)
Filed October 31, 2022 10 a.m. EST
Through November 4, 2022 10 a.m.
EST
Pursuant to 40 CFR 1506.9.
Notice
lotter on DSK11XQN23PROD with NOTICES1
27/2022, Contact: Cindy Eck 301–
851–3892.
EIS No. 20220162, Draft, USDA, OR,
Predator Damage Management in
Oregon, Comment Period Ends: 12/
27/2022, Contact: Kevin Christensen
503–820–2751.
EIS No. 20220163, Draft, TxDOT, TX,
Loop 9 Segment A, Comment Period
Ends: 01/03/2023, Contact: Doug
Booher 512–416–2663.
Section 309(a) of the Clean Air Act
requires that EPA make public its
comments on EISs issued by other
Federal agencies. EPA’s comment letters
on EISs are available at: https://
cdxapps.epa.gov/cdx-enepa-II/public/
action/eis/search.
EIS No. 20220160, Draft, FERC, ND,
Wahpeton Expansion Project,
Comment Period Ends: 12/27/2022,
Contact: Office of External Affairs
866–208–3372.
EIS No. 20220161, Draft, APHIS, NAT,
The State University of New York
College of Environmental Science and
Forestry Petition (19–309–01p) for
Determination of Nonregulated Status
for Blight-Tolerant Darling 58
American Chestnut (Castanea
dentata), Comment Period Ends: 12/
VerDate Sep<11>2014
17:43 Nov 09, 2022
Jkt 259001
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Environmental Protection
Agency (EPA) is announcing the
availability of the final revision to the
risk determination for the methylene
chloride risk evaluation issued under
the Toxic Substances Control Act
(TSCA). The revision to the methylene
chloride risk determination reflects the
announced policy changes to ensure the
public is protected from unreasonable
risks from chemicals in a way that is
supported by science and the law. EPA
determined that methylene chloride, as
a whole chemical substance, presents an
unreasonable risk of injury to health
when evaluated under its conditions of
use. In addition, this revised risk
determination does not reflect an
assumption that workers always
appropriately wear personal protective
equipment (PPE). EPA understands that
there could be occupational safety
protections in place at workplace
locations; however, not assuming use of
PPE reflects EPA’s recognition that
unreasonable risk may exist for
SUMMARY:
Frm 00047
Fmt 4703
subpopulations of workers that may be
highly exposed because they are not
covered by Occupational Safety and
Health Administration (OSHA)
standards, or their employers are out of
compliance with OSHA standards, or
because many of OSHA’s chemicalspecific permissible exposure limits
largely adopted in the 1970’s are
described by OSHA as being ‘‘outdated
and inadequate for ensuring protection
of worker health,’’ or because the OSHA
permissible exposure limit (PEL) alone
may be inadequate for ensuring
protection of worker health, or because
EPA finds unreasonable risk for
purposes of TSCA notwithstanding
OSHA requirements. This revision
supersedes the condition of use-specific
no unreasonable risk determinations in
the June 2020 Methylene Chloride Risk
Evaluation and withdraws the
associated TSCA order included in the
June 2020 Methylene Chloride Risk
Evaluation.
The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPPT–2016–0742, is
available online at https://
www.regulations.gov or in-person at the
Office of Pollution Prevention and
Toxics Docket (OPPT Docket),
Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the OPPT
Docket is (202) 566–0280. Additional
instructions on visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/dockets.
ADDRESSES:
Methylene Chloride; Revision to Toxic
Substances Control Act (TSCA) Risk
Determination; Notice of Availability
PO 00000
67901
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
For technical information contact:
Ingrid Feustel, Office of Pollution
Prevention and Toxics (7404M),
Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC
20460–0001; telephone number: (202)
564–3199; email address:
Feustel.Ingrid@EPA.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\10NON1.SGM
10NON1
67902
Federal Register / Vol. 87, No. 217 / Thursday, November 10, 2022 / Notices
I. General Information
lotter on DSK11XQN23PROD with NOTICES1
A. Does this action apply to me?
This action is directed to the public
in general and may be of interest to
those involved in the manufacture,
processing, distribution, use, disposal,
and/or the assessment of risks involving
chemical substances and mixtures. You
may be potentially affected by this
action if you manufacture (defined
under TSCA to include import), process
(including recycling), distribute in
commerce, use or dispose of methylene
chloride, including methylene chloride
in products. Since other entities may
also be interested in this revision to the
risk determination, EPA has not
attempted to describe all the specific
entities that may be affected by this
action.
B. What is EPA’s authority for taking
this action?
TSCA section 6, 15 U.S.C. 2605,
requires EPA to conduct risk
evaluations to determine whether a
chemical substance presents an
unreasonable risk of injury to health or
the environment, without consideration
of costs or other nonrisk factors,
including an unreasonable risk to a
potentially exposed or susceptible
subpopulation (PESS) identified as
relevant to the risk evaluation by the
Administrator, under the conditions of
use. 15 U.S.C. 2605(b)(4)(A). TSCA
sections 6(b)(4)(A) through (H)
enumerate the deadlines and minimum
requirements applicable to this process,
including provisions that provide
instruction on chemical substances that
must undergo evaluation, the minimum
components of a TSCA risk evaluation,
and the timelines for public comment
and completion of the risk evaluation.
TSCA also requires that EPA operate in
a manner that is consistent with the best
available science, make decisions based
on the weight of the scientific evidence,
and consider reasonably available
information. 15 U.S.C. 2625(h), (i), and
(k).
The statute identifies the minimum
components for all chemical substance
risk evaluations. For each risk
evaluation, EPA must publish a
document that outlines the scope of the
risk evaluation to be conducted, which
includes the hazards, exposures,
conditions of use, and the potentially
exposed or susceptible subpopulations
that EPA expects to consider. 15 U.S.C.
2605(b)(4)(D). The statute further
provides that each risk evaluation must
also: (1) integrate and assess available
information on hazards and exposures
for the conditions of use of the chemical
substance, including information that is
VerDate Sep<11>2014
17:43 Nov 09, 2022
Jkt 259001
relevant to specific risks of injury to
health or the environment and
information on relevant potentially
exposed or susceptible subpopulations;
(2) describe whether aggregate or
sentinel exposures were considered and
the basis for that consideration; (3) take
into account, where relevant, the likely
duration, intensity, frequency, and
number of exposures under the
conditions of use; and (4) describe the
weight of the scientific evidence for the
identified hazards and exposures. 15
U.S.C. 2605(b)(4)(F)(i) through (ii) and
(iv) through (v). Each risk evaluation
must not consider costs or other nonrisk
factors. 15 U.S.C. 2605(b)(4)(F)(iii).
EPA has inherent authority to
reconsider previous decisions and to
revise, replace, or repeal a decision to
the extent permitted by law and
supported by reasoned explanation. FCC
v. Fox Television Stations, Inc., 556 U.S.
502, 515 (2009); see also Motor Vehicle
Mfrs. Ass’n v. State Farm Mutual Auto.
Ins. Co., 463 U.S. 29, 42 (1983).
C. What action is EPA taking?
EPA is announcing the availability of
the final revision to the risk
determination for the methylene
chloride risk evaluation issued under
TSCA that published in June 2020 (Ref.
1). In July 2022, EPA sought public
comment on the draft revisions (87 FR
39824, July 5, 2022). EPA appreciates
the public comments received on the
draft revision to the methylene chloride
risk determination. After review of these
comments and consideration of the
specific circumstances of methylene
chloride, EPA concludes that the
Agency’s risk determination for
methylene chloride is better
characterized as a whole chemical risk
determination rather than condition-ofuse-specific risk determinations.
Accordingly, EPA is revising and
replacing Section 5 of the June 2020
Methylene Chloride Risk Evaluation
(Ref. 2) where the findings of
unreasonable risk to health were
previously made for the individual
conditions of use evaluated. EPA is also
withdrawing the previously issued
TSCA section 6(i)(l) order for six
conditions of use previously determined
not to present unreasonable risk which
was included in Section 5.4.1 of the
June 2020 Methylene Chloride Risk
Evaluation (Ref. 2).
This final revision to the methylene
chloride risk determination is consistent
with EPA’s plans to revise specific
aspects of the first ten TSCA chemical
risk evaluations to ensure that the risk
evaluations better align with TSCA’s
objective of protecting health and the
environment. As a result of this
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
revision, removing the assumption that
workers always and appropriately wear
PPE (see Unit II.C.) means that: five
additional conditions of use in addition
to the original 47 drive the unreasonable
risk determination for methylene
chloride; inhalation risk to workers in
addition to the previously identified
inhalation risk to occupational nonusers (ONUs) drive the unreasonable
risk in three conditions of use; and
additional risk to workers for acute and
chronic non-cancer dermal exposures
and for cancer from inhalation
exposures also drive the unreasonable
risk in many of those 52 conditions of
use (where previously those conditions
of use were identified as presenting
unreasonable risk only for chronic noncancer effects and/or acute effects).
However, EPA is not making conditionof-use-specific risk determinations for
those conditions of use, and for
purposes of TSCA section 6(i), EPA is
not issuing a final order under TSCA
section 6(i)(1) and does not consider the
revised risk determination to constitute
a final agency action at this point in
time. Overall, 52 conditions of use out
of 53 EPA evaluated drive the
methylene chloride whole chemical
unreasonable risk determination due to
risks identified for human health. The
full list of the conditions of use
evaluated for the methylene chloride
TSCA risk evaluation is in Tables 4–2
and 4–3 of the June 2020 Methylene
Chloride Risk Evaluation (Ref. 2).
II. Background
A. Why is EPA re-issuing the risk
determination for the methylene
chloride risk evaluation conducted
under TSCA?
In accordance with Executive Order
13990 (‘‘Protecting Public Health and
the Environment and Restoring Science
to Tackle the Climate Crisis’’) and other
Administration priorities (Refs. 3, 4, 5,
and 6), EPA reviewed the risk
evaluations for the first ten chemical
substances, including methylene
chloride, to ensure that they meet the
requirements of TSCA, including
conducting decision-making in a
manner that is consistent with the best
available science.
As a result of this review, EPA
announced plans to revise specific
aspects of the first ten risk evaluations
in order to ensure that the risk
evaluations appropriately identify
unreasonable risks and thereby help
ensure the protection of human health
and the environment (Ref. 7). Following
a review of specific aspects of the June
2020 Methylene Chloride Risk
Evaluation (Ref. 2) and after considering
E:\FR\FM\10NON1.SGM
10NON1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 217 / Thursday, November 10, 2022 / Notices
comments received on a draft revised
risk determination for methylene
chloride, EPA has determined that
making an unreasonable risk
determination for methylene chloride as
a whole chemical substance, rather than
making unreasonable risk
determinations separately on each
individual condition of use evaluated in
the risk evaluation, is the most
appropriate approach for methylene
chloride under the statute and
implementing regulations. In addition,
EPA’s final risk determination is
explicit insofar as it does not rely on
assumptions regarding the use of PPE in
making the unreasonable risk
determination under TSCA section 6,
even though some facilities might be
using PPE as one means to reduce
worker exposures; rather, the use of PPE
as a means of addressing unreasonable
risk will be considered during risk
management, as appropriate.
Separately, EPA is conducting a
screening approach to assess potential
risks from the air and water pathways
for several of the first 10 chemicals,
including this chemical. For methylene
chloride the exposure pathways that
were or could be regulated under
another EPA administered statute were
excluded from the final risk evaluation
(see section 1.4.2 of the June 2020
Methylene Chloride Risk Evaluation).
This resulted in the surface water,
drinking water and ambient air
pathways for methylene chloride not
being assessed. The goal of the recentlydeveloped screening approach is to
remedy this exclusion and to identify if
there may be risks that were
unaccounted for in the methylene
chloride risk evaluation.
The screening-level approach has
gone through public comment and
independent external peer review
through the SACC. The Agency received
the final peer review report on May 18,
2022, and has reviewed public
comments and SACC comments. EPA
expects to describe its views regarding
the chemical-specific application of this
screening-level approach in the
forthcoming proposed rule under TSCA
section 6(a) for methylene chloride.
This action pertains only to the risk
determination for methylene chloride.
While EPA intends to consider and may
take additional similar actions on other
of the first ten chemicals, EPA is taking
a chemical-specific approach to
reviewing these risk evaluations and is
incorporating new policy direction in a
surgical manner, while being mindful of
Congressional direction on the need to
complete risk evaluations and move
toward any associated risk management
VerDate Sep<11>2014
17:43 Nov 09, 2022
Jkt 259001
activities in accordance with statutory
deadlines.
B. What is a whole chemical view of the
unreasonable risk determination for the
methylene chloride risk evaluation?
TSCA section 6 repeatedly refers to
determining whether a chemical
substance presents unreasonable risk
under its conditions of use.
Stakeholders have disagreed over
whether a chemical substance should
receive: A single determination that is
comprehensive for the chemical
substance after considering the
conditions of use, referred to as a wholechemical determination; or multiple
determinations, each of which is
specific to a condition of use, referred
to as condition-of-use-specific
determinations.
As explained in the Federal Register
document announcing the availability of
the draft revised risk determination for
methylene chloride (87 FR 39824, July
5, 2022 (FRL–9946–01–OCSPP)), the
proposed Risk Evaluation Procedural
Rule (Ref. 8) was premised on the whole
chemical approach to making
unreasonable risk determinations. In
that proposed rule, EPA acknowledged
a lack of specificity in statutory text that
might lead to different views about
whether the statute compelled EPA’s
risk evaluations to address all
conditions of use of a chemical
substance or whether EPA had
discretion to evaluate some subset of
conditions of use (i.e., to scope out some
manufacturing, processing, distribution
in commerce, use, or disposal
activities), but also stated that ‘‘EPA
believes the word ‘the’ [in TSCA section
6(b)(4)(A)] is best interpreted as calling
for evaluation that considers all
conditions of use.’’ The proposed rule,
however, was unambiguous on the point
that unreasonable risk determinations
would be for the chemical substance as
a whole, even if based on a subset of
uses. See Ref. 8 at pages 7565–66
(‘‘TSCA section 6(b)(4)(A) specifies that
a risk evaluation must determine
whether ‘a chemical substance’ presents
an unreasonable risk of injury to health
or the environment ‘under the
conditions of use.’ The evaluation is on
the chemical substance—not individual
conditions of use—and it must be based
on ‘the conditions of use.’ In this
context, EPA believes the word ‘the’ is
best interpreted as calling for evaluation
that considers all conditions of use.’’).
In the proposed regulatory text, EPA
proposed to determine whether the
chemical substance presents an
unreasonable risk of injury to health or
the environment under the conditions of
use. (Ref. 8 at 7480.)
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
67903
The final Risk Evaluation Procedural
Rule stated (82 FR 33726, July 20, 2017
(FRL–9964–38)) (Ref. 9): ‘‘As part of the
risk evaluation, EPA will determine
whether the chemical substance
presents an unreasonable risk of injury
to health or the environment under each
condition of uses [sic] within the scope
of the risk evaluation, either in a single
decision document or in multiple
decision documents’’ (40 CFR 702.47).
For the unreasonable risk
determinations in the first ten risk
evaluations, EPA applied this provision
by making individual risk
determinations for each condition of use
evaluated as part of each risk evaluation
document (i.e., the condition-of-usespecific approach to risk
determinations). That approach was
based on one particular passage in the
preamble to the final Risk Evaluation
Rule which stated that EPA will make
individual risk determinations for all
conditions of use identified in the
scope. (Ref. 9 at 33744).
In contrast to this portion of the
preamble of the final Risk Evaluation
Rule, the regulatory text itself and other
statements in the preamble reference a
risk determination for the chemical
substance under its conditions of use,
rather than separate risk determinations
for each of the conditions of use of a
chemical substance. In the key
regulatory provision excerpted
previously from 40 CFR 702.47, the text
explains that ‘‘[a]s part of the risk
evaluation, EPA will determine whether
the chemical substance presents an
unreasonable risk of injury to health or
the environment under each condition
of uses [sic] within the scope of the risk
evaluation, either in a single decision
document or in multiple decision
documents’’ (Ref. 9, emphasis added).
Other language reiterates this
perspective. For example, 40 CFR
702.31(a) states that the purpose of the
rule is to establish the EPA process for
conducting a risk evaluation to
determine whether a chemical
substance presents an unreasonable risk
of injury to health or the environment
as required under TSCA section
6(b)(4)(B). Likewise, there are recurring
references to whether the chemical
substance presents an unreasonable risk
in 40 CFR 702.41(a). See, for example,
40 CFR 702.41(a)(6), which explains
that the extent to which EPA will refine
its evaluations for one or more
condition of use in any risk evaluation
will vary as necessary to determine
whether a chemical substance presents
an unreasonable risk. Notwithstanding
the one preambular statement about
condition-of-use-specific risk
E:\FR\FM\10NON1.SGM
10NON1
lotter on DSK11XQN23PROD with NOTICES1
67904
Federal Register / Vol. 87, No. 217 / Thursday, November 10, 2022 / Notices
determinations, the preamble to the
final rule also contains support for a risk
determination on the chemical
substance as a whole. In discussing the
identification of the conditions of use of
a chemical substance, the preamble
notes that this task inevitably involves
the exercise of discretion on EPA’s part,
and ‘‘as EPA interprets the statute, the
Agency is to exercise that discretion
consistent with the objective of
conducting a technically sound,
manageable evaluation to determine
whether a chemical substance—not just
individual uses or activities—presents
an unreasonable risk’’ (Ref. 9 at 33729).
Therefore, notwithstanding EPA’s
choice to issue condition-of-use-specific
risk determinations to date, EPA
interprets its risk evaluation regulation
to also allow the Agency to issue wholechemical risk determinations. Either
approach is permissible under the
regulation. A panel of the Ninth Circuit
Court of Appeals also recognized the
ambiguity of the regulation on this
point. Safer Chemicals v. EPA, 943 F.3d.
397, 413 (9th Cir. 2019) (holding a
challenge about ‘‘use-by-use risk
evaluations [was] not justiciable because
it is not clear, due to the ambiguous text
of the Risk Evaluation Rule, whether the
Agency will actually conduct risk
evaluations in the manner Petitioners
fear’’).
EPA plans to consider the appropriate
approach for each chemical substance
risk evaluation on a case-by-case basis,
taking into account considerations
relevant to the specific chemical
substance in light of the Agency’s
obligations under TSCA. The Agency
expects that this case-by-case approach
will provide greater flexibility in the
Agency’s ability to evaluate and manage
unreasonable risk from individual
chemical substances. EPA believes this
is a reasonable approach under TSCA
and the Agency’s implementing
regulations.
With regard to the specific
circumstances of methylene chloride,
EPA has determined that a whole
chemical approach is appropriate for
methylene chloride in order to protect
health. The whole chemical approach is
appropriate for methylene chloride
because there are benchmark
exceedances for a substantial number of
conditions of use (spanning across most
aspects of the chemical lifecycle–from
manufacturing (including import),
processing, industrial and commercial
use, consumer use, and disposal) for
workers, occupational non-users,
consumers, and bystanders and
irreversible health effects (specifically
cancer, coma, hypoxia, and death)
associated with methylene chloride
VerDate Sep<11>2014
17:43 Nov 09, 2022
Jkt 259001
exposures. Because these chemicalspecific properties cut across the
conditions of use within the scope of
the risk evaluation, a substantial
number of the conditions of use drive
the unreasonable risk; therefore, it is
appropriate for the Agency to make a
determination for methylene chloride
that the whole chemical presents an
unreasonable risk.
As explained later in this document,
the revisions to the unreasonable risk
determination (Section 5 of the June
2020 Methylene Chloride Risk
Evaluation (Ref. 2)) follow the issuance
of a draft revision to the TSCA
methylene chloride unreasonable risk
determination (87 FR 39824, July 5,
2022) and the receipt of public
comment. A response to comments
document is also being issued with the
final revised unreasonable risk
determination for methylene chloride
(Ref. 10). The revisions to the
unreasonable risk determination are
based on the existing risk
characterization section of the June 2020
Methylene Chloride Risk Evaluation
(Ref. 2) (Section 4) and do not involve
additional technical or scientific
analysis. The discussion of the issues in
this Federal Register document and in
the accompanying final revised risk
determination for methylene chloride
supersede any conflicting statements in
the June 2020 Methylene Chloride Risk
Evaluation (Ref. 2) and the earlier
response to comments document (Ref.
11). EPA views the peer reviewed
hazard and exposure assessments and
associated risk characterization as
robust and upholding the standards of
best available science and weight of the
scientific evidence per TSCA sections
26(h) and (i).
For purposes of TSCA section 6(i),
EPA is making a risk determination on
methylene chloride as a whole
chemical. Under the revised approach,
the ‘‘whole chemical’’ risk
determination for methylene chloride
supersedes the no unreasonable risk
determinations for methylene chloride
that were premised on a condition-ofuse-specific approach to determining
unreasonable risk and also contains an
order withdrawing the TSCA section
6(i)(1) order in Section 5.4.1 of the June
2020 Methylene Chloride Risk
Evaluation (Ref. 2).
C. What revision is EPA now making
final about the use of PPE for the
methylene chloride risk evaluation?
In the risk evaluations for the first ten
chemical substances, as part of the
unreasonable risk determination, EPA
assumed for several conditions of use
that workers were provided and always
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
used PPE in a manner that achieves the
stated assigned protection factor (APF)
for respiratory protection, or used
impervious gloves for dermal
protection. In support of this
assumption, EPA used reasonably
available information such as public
comments indicating that some
employers, particularly in the industrial
setting, provide PPE to their employees
and follow established worker
protection standards (e.g., OSHA
requirements for protection of workers).
For the June 2020 Methylene Chloride
Risk Evaluation (Ref. 2), EPA assumed,
based on reasonably available
information, including public comment
and safety data sheets for methylene
chloride, that workers use PPE—
specifically respirators with an APF
ranging from 25 to 50—for 26
occupational conditions of use and
gloves with PF 10 or 20 for 39
occupational conditions of use.
However, in the June 2020 Methylene
Chloride Risk Evaluation, EPA
determined that there is unreasonable
risk to workers for 32 of those
conditions of use.
EPA is revising the assumption for
methylene chloride that workers always
and properly use PPE, although it does
not question the public comments
received regarding the occupational
safety practices often followed by
industry respondents. When
characterizing the risk to human health
from occupational exposures during risk
evaluation under TSCA, EPA believes it
is appropriate to evaluate the levels of
risk present in baseline scenarios where
PPE is not assumed to be used by
workers. This approach of not assuming
PPE use by workers considers the risk
to potentially exposed or susceptible
subpopulations of workers who may not
be covered by OSHA standards, such as
self-employed individuals and public
sector workers who are not covered by
a State Plan. It should be noted that, in
some cases, baseline conditions may
reflect certain mitigation measures, such
as engineering controls, in instances
where exposure estimates are based on
monitoring data at facilities that have
engineering controls in place.
In addition, EPA believes it is
appropriate to evaluate the levels of risk
present in scenarios considering
applicable OSHA requirements (e.g.,
chemical-specific permissible exposure
limits (PELs) and/or chemical-specific
PELs with additional substance-specific
standards), as well as scenarios
considering industry or sector best
practices for industrial hygiene that are
clearly articulated to the Agency.
Consistent with this approach, the June
2020 Methylene Chloride Risk
E:\FR\FM\10NON1.SGM
10NON1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 217 / Thursday, November 10, 2022 / Notices
Evaluation (Ref. 2) characterized risk to
workers both with and without the use
of PPE. By characterizing risks using
scenarios that reflect different levels of
mitigation, EPA risk evaluations can
help inform potential risk management
actions by providing information that
could be used during risk management
to tailor risk mitigation appropriately to
address any unreasonable risk
identified, or to ensure that applicable
OSHA requirements or industry or
sector best practices that address the
unreasonable risk are required for all
potentially exposed and susceptible
subpopulations (including selfemployed individuals and public sector
workers who are not covered by an
OSHA State Plan).
When undertaking unreasonable risk
determinations as part of TSCA risk
evaluations, however, EPA does not
believe it is appropriate to assume as a
general matter that an applicable OSHA
requirement or industry practice related
to PPE use is consistently and always
properly applied. Mitigation scenarios
included in the EPA risk evaluation
(e.g., scenarios considering use of
various PPE) likely represent what is
happening already in some facilities.
However, the Agency cannot assume
that all facilities have adopted these
practices for the purposes of making the
TSCA risk determination (Ref. 12).
Therefore, EPA is making a
determination of unreasonable risk for
methylene chloride from a baseline
scenario that does not assume
compliance with OSHA standards,
including any applicable exposure
limits or requirements for use of
respiratory protection or other PPE.
Making unreasonable risk
determinations based on the baseline
scenario should not be viewed as an
indication that EPA believes there are
no occupational safety protections in
place at any location, or that there is
widespread non-compliance with
applicable OSHA standards. Rather, it
reflects EPA’s recognition that
unreasonable risk may exist for
subpopulations of workers that may be
highly exposed because they are not
covered by OSHA standards, such as
self-employed individuals and public
sector workers who are not covered by
a State Plan, or because their employer
is out of compliance with OSHA
standards, or because many of OSHA’s
chemical-specific permissible exposure
limits largely adopted in the 1970’s are
described by OSHA as being ‘‘outdated
and inadequate for ensuring protection
of worker health,’’ (Ref. 13) or because
the OSHA Permissible Exposure Limit
alone may be inadequate to protect
human health, or because EPA finds
VerDate Sep<11>2014
17:43 Nov 09, 2022
Jkt 259001
unreasonable risk for purposes of TSCA
notwithstanding OSHA requirements.
In accordance with this approach,
EPA is finalizing the revision to the
methylene chloride risk determination
without relying on assumptions
regarding the occupational use of PPE in
making the unreasonable risk
determination under TSCA section 6;
rather, information on the use of PPE as
a means of mitigating risk (including
public comments received from
industry respondents about
occupational safety practices in use)
will be considered during the risk
management phase, as appropriate. This
represents a change from the approach
taken in the June 2020 Methylene
Chloride Risk Evaluation (Ref. 2). As a
general matter, when undertaking risk
management actions, EPA intends to
strive for consistency with applicable
OSHA requirements and industry best
practices, including appropriate
application of the hierarchy of controls,
to the extent that applying those
measures would address the identified
unreasonable risk, including
unreasonable risk to potentially exposed
or susceptible subpopulations.
Consistent with TSCA section 9(d), EPA
will consult and coordinate TSCA
activities with OSHA and other relevant
Federal agencies for the purpose of
achieving the maximum applicability of
TSCA while avoiding the imposition of
duplicative requirements. Informed by
the mitigation scenarios and
information gathered during the risk
evaluation and risk management
process, the Agency might propose rules
that require risk management practices
that may be already common practice in
many or most facilities. Adopting clear,
comprehensive regulatory standards
will foster compliance across all
facilities (ensuring a level playing field)
and assure protections for all affected
workers, especially in cases where
current OSHA standards may not apply
or be sufficient to address the
unreasonable risk.
Removing the assumption that
workers always and appropriately wear
PPE in making the whole chemical risk
determination for methylene chloride
means that: five conditions of use in
addition to the original 47 conditions of
use drive the unreasonable risk for
methylene chloride; an additional route
of exposure (i.e., inhalation) is also
identified as driving the unreasonable
risk to workers in three conditions of
use in addition to the previously
identified inhalation risk to
occupational non-users; and additional
risks to workers for acute and chronic
non-cancer dermal exposures and for
cancer from inhalation exposures also
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
67905
drive the unreasonable risk in many of
those 52 conditions of use (where
previously those conditions of use were
identified as presenting unreasonable
risk only for chronic non-cancer effects
and/or acute effects). The finalized
revision to the methylene chloride risk
determination clarifies that EPA does
not rely on the assumed use of PPE
when making the risk determination for
the whole substance.
D. What is methylene chloride?
Methylene chloride, which is also
called dichloromethane, is a volatile
chemical that is produced and imported
into the United States, with use
estimated at over 260 million pounds
per year. It is a solvent used in a variety
of industries and applications, such as
adhesives, paint and coating products,
metal cleaning, chemical processing,
and aerosols. In addition, it is used as
a propellent, processing aid, or
functional fluid in the manufacturing of
other chemicals. A variety of consumer
and commercial products use methylene
chloride as a solvent including sealants,
automotive products, and paint and
coating removers. Methylene chloride is
subject to federal and state regulations
and reporting requirements.
E. What conclusions is EPA finalizing
today in the revised TSCA risk
evaluation based on the whole chemical
approach and not assuming the use of
PPE?
EPA determined that methylene
chloride presents an unreasonable risk
to health under the conditions of use.
EPA’s unreasonable risk determination
for methylene chloride as a chemical
substance is driven by risks associated
with the following conditions of use,
considered singularly or in combination
with other exposures:
• Manufacturing—Domestic
manufacture;
• Manufacturing—Import;
• Processing into a formulation,
mixture, or reaction product;
• Processing as a reactant;
• Processing: recycling;
• Repackaging;
• Industrial and commercial use as
solvent for batch vapor degreasing;
• Industrial and commercial use as
solvent for in-line vapor degreasing;
• Industrial and commercial use as
solvent for cold cleaning; and
commercial use as a solvent for aerosol
spray degreasers/cleaners;
• Industrial and commercial use in
adhesives, sealants, and caulks;
• Industrial and commercial use in
paints and coatings;
• Industrial and commercial use in
paint and coating removers;
E:\FR\FM\10NON1.SGM
10NON1
lotter on DSK11XQN23PROD with NOTICES1
67906
Federal Register / Vol. 87, No. 217 / Thursday, November 10, 2022 / Notices
• Industrial and commercial use in
adhesive and caulk removers;
• Industrial and commercial use as
metal aerosol degreasers;
• Industrial and commercial use in
metal non-aerosol degreasers;
• Industrial and commercial use in
finishing products for fabric, textiles,
and leather;
• Industrial and commercial use in
automotive care products (functional
fluids for air conditioners);
• Industrial and commercial use in
automotive care products (interior car
care);
• Industrial and commercial use in
automotive care products (degreasers);
• Industrial and commercial use in
apparel and footwear care products;
• Industrial and commercial use in
spot removers for apparel and textiles;
• Industrial and commercial use in
liquid lubricants and greases;
• Industrial and commercial use in
spray lubricants and greases;
• Industrial and commercial use in
aerosol degreasers and cleaners;
• Industrial and commercial use in
non-aerosol degreasers and cleaners;
• Industrial and commercial use in
cold pipe insulations;
• Industrial and commercial use as
solvent that becomes part of a
formulation or mixture;
• Industrial and commercial use as a
processing aid;
• Industrial and commercial use as
propellant and blowing agent;
• Industrial and commercial use for
electrical equipment, appliance, and
component manufacturing;
• Industrial and commercial use for
plastic and rubber products
manufacturing;
• Industrial and commercial use for
cellulose triacetate film production;
• Industrial and commercial use as
anti-spatter welding aerosol;
• Industrial and commercial use for
oil and gas drilling, extraction, and
support activities;
• Industrial and commercial uses for
toys, playgrounds, and sporting
equipments (including novelty articles);
• Industrial and commercial use for
carbon removers, wood floor cleaners,
and brush cleaners;
• Industrial and commercial use as a
lithographic printing plate cleaner;
• Industrial and commercial use as a
laboratory chemical;
• Consumer use as a solvent in an
aerosol cleaner/degreaser;
• Consumer use in adhesives and
sealants;
• Consumer use in paints and
coatings (brush cleaners for paints and
coatings);
• Consumer use in adhesives/caulk
removers;
VerDate Sep<11>2014
17:43 Nov 09, 2022
Jkt 259001
• Consumer use in aerosol and nonaerosol metal degreasers;
• Consumer use in automotive
functional fluids (air conditioners
refrigerant, treatment, leak sealer);
• Consumer use in automotive
degreasers (gasket remover,
transmission cleaners, carburetor);
• Consumer use in aerosol and nonaerosol lubricants and greases,
consumer use in cold pipe insulation;
• Consumer use in aerosol and nonaerosol lubricants/greases and aerosol
and non-aerosol degreaser/cleaners;
• Consumer use in cold pipe
insulation;
• Consumer use in crafting glue and
cement/concrete;
• Consumer use in anti-adhesive
agent—anti-spatter welding aerosol;
• Consumer use in carbon remover
and brush cleaner; and
• Disposal.
The following condition of use does
not drive EPA’s unreasonable risk
determination for methylene chloride:
• Distribution in commerce.
EPA is not making a condition of usespecific risk determination for this
condition of use, is not issuing a final
order under TSCA section 6(i)(1) for this
condition of use, and does not consider
the revised risk determination for
methylene chloride to constitute a final
agency action at this point in time.
Consistent with the statutory
requirements of TSCA section 6(a), EPA
will propose a risk management
regulatory action to the extent necessary
so that methylene chloride no longer
presents an unreasonable risk. EPA
expects to focus its risk management
action on the conditions of use that
drive the unreasonable risk. However, it
should be noted that, under TSCA
section 6(a), EPA is not limited to
regulating the specific activities found
to drive unreasonable risk and may
select from among a suite of risk
management requirements in section
6(a) related to manufacture (including
import), processing, distribution in
commerce, commercial use, and
disposal as part of its regulatory options
to address the unreasonable risk. As a
general example, EPA may regulate
upstream activities (e.g., processing,
distribution in commerce) to address
downstream activities (e.g., consumer
uses) driving unreasonable risk, even if
the upstream activities do not drive the
unreasonable risk.
III. Summary of Public Comments
EPA received a total of 20 public
comments on the July 5, 2022, draft
revised risk determination for
methylene chloride during the comment
period that ended August 4, 2022, of
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
which 19 were unique and responsive to
the request for comments. Commenters
included trade organizations, industry
stakeholders, environmental groups,
and non-governmental health advocacy
organizations. A separate document that
summarizes all comments submitted
and EPA’s responses to those comments
has been prepared and is available in
the docket for this notice (Ref. 10).
IV. Revision of the June 2020 Methylene
Chloride Risk Evaluation
A. Why is EPA revising the risk
determination for the methylene
chloride risk evaluation?
EPA is finalizing the revised risk
determination for the methylene
chloride risk evaluation pursuant to
TSCA section 6(b) and consistent with
Executive Order 13990, (‘‘Protecting
Public Health and the Environment and
Restoring Science to Tackle the Climate
Crisis’’) and other Administration
priorities (Refs. 3, 4, 5, and 6). EPA is
revising specific aspects of the first ten
TSCA existing chemical risk evaluations
in order to ensure that the risk
evaluations better align with TSCA’s
objective of protecting health and the
environment. For the methylene
chloride risk evaluation, this includes:
(1) Making the risk determination in this
instance based on the whole chemical
substance instead of by individual
conditions of use and (2) Emphasizing
that EPA does not rely on the assumed
use of PPE when making the risk
determination.
B. What are the revisions?
EPA is now finalizing the revised risk
determination for the June 2020
Methylene Chloride Risk Evaluation
(Ref. 2) pursuant to TSCA section 6(b).
Under the revised determination (Ref.
1), EPA concludes that methylene
chloride, as evaluated in the risk
evaluation as a whole, presents an
unreasonable risk of injury to health
when evaluated under its conditions of
use. This revision replaces the previous
unreasonable risk determinations made
for methylene chloride by individual
conditions of use, supersedes the
determinations (and withdraws the
associated order) of no unreasonable
risk for the conditions of use identified
in the TSCA section 6(i)(1) no
unreasonable risk order, and clarifies
the lack of reliance on assumed use of
PPE as part of the risk determination.
These revisions do not alter any of the
underlying technical or scientific
information that informs the risk
characterization, and as such the
hazard, exposure, and risk
characterization sections are not
E:\FR\FM\10NON1.SGM
10NON1
Federal Register / Vol. 87, No. 217 / Thursday, November 10, 2022 / Notices
changed, except to statements about PPE
assumptions in Section 2.4.1.1
(Consideration of Engineering Controls
and PPE). The discussion of the issues
in this Notice and in the accompanying
final revision to the risk determination
supersede any conflicting statements in
the prior executive summary, and
Section 2.4.1.1 from the June 2020
Methylene Chloride Risk Evaluation
(Ref. 2) and the response to comments
document (Ref. 11).
The revised unreasonable risk
determination for methylene chloride
includes additional explanation of how
the risk evaluation characterizes the
applicable OSHA requirements, or
industry or sector best practices, and
also clarifies that no additional analysis
was done, and the risk determination is
based on the risk characterization
(Section 4) of the June 2020 Methylene
Chloride Risk Evaluation (Ref. 2).
C. Will the revised risk determination be
peer reviewed?
The risk determination (Section 5 of
the June 2020 Methylene Chloride Risk
Evaluation (Ref. 2)) was not part of the
scope of the Science Advisory
Committee on Chemicals (SACC) peer
review of the methylene chloride risk
evaluation. Thus, consistent with that
approach, EPA did not conduct peer
review of the final revised unreasonable
risk determination for the methylene
chloride risk evaluation because no
technical or scientific changes were
made to the hazard or exposure
assessments or the risk characterization.
lotter on DSK11XQN23PROD with NOTICES1
V. Order Withdrawing Previous Order
Regarding Unreasonable Risk
Determinations for Certain Conditions
of Use
EPA is also issuing a new order to
withdraw the TSCA Section 6(i)(1) no
unreasonable risk order issued in
Section 5.4.1 of the 2020 methylene
chloride Risk Evaluation (Ref. 2). This
final revised risk determination
supersedes the condition of use-specific
no unreasonable risk determinations in
the June 2020 Methylene Chloride Risk
Evaluation (Ref. 2). The order contained
in Section 5.5 of the revised risk
determination (Ref. 1) withdraws the
TSCA section 6(i)(1) order contained in
Section 5.4.1 of the June 2020
Methylene Chloride Risk Evaluation
(Ref. 2). Consistent with the statutory
requirements of section 6(a), the Agency
will propose risk management action to
address the unreasonable risk
determined in the methylene chloride
risk evaluation.
VerDate Sep<11>2014
17:43 Nov 09, 2022
Jkt 259001
VI. References
The following is a listing of the
documents that are specifically
referenced in this document. The docket
includes these documents and other
information considered by EPA,
including documents that are referenced
within the documents that are included
in the docket, even if the referenced
document is not physically located in
the docket. For assistance in locating
these other documents, please consult
the person listed under FOR FURTHER
INFORMATION CONTACT.
1. EPA. Unreasonable Risk Determination for
Methylene Chloride. October 2022.
2. EPA. Risk Evaluation for Methylene
Chloride. June 2020. EPA Document
#740–R1–8010. https://
www.regulations.gov/document/EPAHQ-OPPT-2019-0437-0107.
3. Executive Order 13990. Protecting Public
Health and the Environment and
Restoring Science to Tackle the Climate
Crisis. Federal Register (86 FR 7037,
January 25, 2021).
4. Executive Order 13985. Advancing Racial
Equity and Support for Underserved
Communities Through the Federal
Government. Federal Register (86 FR
7009, January 25, 2021).
5. Executive Order 14008. Tackling the
Climate Crisis at Home and Abroad.
Federal Register (86 FR 7619, February
1, 2021).
6. Presidential Memorandum. Memorandum
on Restoring Trust in Government
Through Scientific Integrity and
Evidence-Based Policymaking. Federal
Register (86 FR 8845, February 10, 2021).
7. EPA. Press Release: EPA Announces Path
Forward for TSCA Chemical Risk
Evaluations. June 2021. https://
www.epa.gov/newsreleases/epaannounces-path-forward-tsca-chemicalrisk-evaluations.
8. EPA. Proposed Rule; Procedures for
Chemical Risk Evaluation Under the
Amended Toxic Substances Control Act.
Federal Register (82 FR 7562, January
19, 2017) (FRL–9957–75).
9. EPA. Final Rule; Procedures for Chemical
Risk Evaluation Under the Amended
Toxic Substances Control Act. Federal
Register (82 FR 33726, 33744, July 20,
2017).
10. EPA. Response to Public Comments to the
Revised Unreasonable Risk
Determination; Methylene Chloride
(MC). October 2022.
11. EPA. Summary of External Peer Review
and Public Comments and Disposition
for Methylene Chloride (MC). June 2020.
Available at: https://
www.regulations.gov/document/EPAHQ-OPPT-2019-0437-0083.
12. Occupational Safety and Health
Administration (OSHA). Top 10 Most
Frequently Cited Standards for Fiscal
Year 2021 (Oct. 1, 2020, to Sept. 30,
2021). Accessed October 13, 2022.
https://www.osha.gov/top10cited
standards
13. OSHA. Permissible Exposure Limits—
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
67907
Annotated Tables. Accessed June 13,
2022. https://www.osha.gov/annotatedpels.
Authority: 15 U.S.C. 2601 et seq.
Dated: November 4, 2022.
Michal Freedhoff,
Assistant Administrator, Office of Chemical
Safety and Pollution Prevention.
[FR Doc. 2022–24533 Filed 11–9–22; 8:45 am]
BILLING CODE 6560–50–P
EQUAL EMPLOYMENT OPPORTUNITY
COMMISSION
Agency Information Collection
Activities: Existing Collection
Equal Employment
Opportunity Commission
ACTION: Notice of information
collection—Proposed revision of the
Employer Information Report (EEO–1)
Component 1.
AGENCY:
In accordance with the
Paperwork Reduction Act (PRA), the
Equal Employment Opportunity
Commission (EEOC or Commission)
announces that it intends to submit to
the Office of Management and Budget
(OMB) a request for a three-year PRA
approval of revisions to the currently
approved Component 1 of the Employer
Information Report (EEO–1).1 This PRA
submission for the EEO–1 Component 1
does not change the types of
demographic workforce data historically
collected by the EEO–1 (i.e., employee
data by job category and sex and race or
ethnicity). Rather, as part of this routine
three-year clearance for Component 1
under the PRA, the EEOC seeks OMB
approval of measures that streamline
and modernize how the current EEO–1
Component 1 workforce demographic
data are collected from employers.
DATES: Written comments on this notice
must be submitted on or before January
9, 2023.
SUMMARY:
1 Component 1 of the EEO–1 refers to the
demographic data the EEOC has collected since
1966. The EEOC called its historic, first-time
collection of pay data from certain private
employers and federal contractors Component 2 of
the EEO–1. The Component 2 collection was
completed in February 2020. On July 28, 2022, the
National Academies of Sciences, Engineering, and
Medicine (NASEM) issued a Consensus Study
Report evaluating the Component 2 pay data
collection and providing recommendations for
future data collections. The EEOC is carefully
evaluating NASEM’s recommendations as they
relate to the EEO–1 Component 1 data collection
and may request modification of the EEO–1
Component 1 collection in the future. The
Consensus Report is available at https://nap.
nationalacademies.org/catalog/26581/evaluationof-compensation-data-collected-through-the-eeo-1form.
E:\FR\FM\10NON1.SGM
10NON1
Agencies
[Federal Register Volume 87, Number 217 (Thursday, November 10, 2022)]
[Notices]
[Pages 67901-67907]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24533]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2016-0742; FRL-9946-02-OCSPP]
Methylene Chloride; Revision to Toxic Substances Control Act
(TSCA) Risk Determination; Notice of Availability
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Environmental Protection Agency (EPA) is announcing the
availability of the final revision to the risk determination for the
methylene chloride risk evaluation issued under the Toxic Substances
Control Act (TSCA). The revision to the methylene chloride risk
determination reflects the announced policy changes to ensure the
public is protected from unreasonable risks from chemicals in a way
that is supported by science and the law. EPA determined that methylene
chloride, as a whole chemical substance, presents an unreasonable risk
of injury to health when evaluated under its conditions of use. In
addition, this revised risk determination does not reflect an
assumption that workers always appropriately wear personal protective
equipment (PPE). EPA understands that there could be occupational
safety protections in place at workplace locations; however, not
assuming use of PPE reflects EPA's recognition that unreasonable risk
may exist for subpopulations of workers that may be highly exposed
because they are not covered by Occupational Safety and Health
Administration (OSHA) standards, or their employers are out of
compliance with OSHA standards, or because many of OSHA's chemical-
specific permissible exposure limits largely adopted in the 1970's are
described by OSHA as being ``outdated and inadequate for ensuring
protection of worker health,'' or because the OSHA permissible exposure
limit (PEL) alone may be inadequate for ensuring protection of worker
health, or because EPA finds unreasonable risk for purposes of TSCA
notwithstanding OSHA requirements. This revision supersedes the
condition of use-specific no unreasonable risk determinations in the
June 2020 Methylene Chloride Risk Evaluation and withdraws the
associated TSCA order included in the June 2020 Methylene Chloride Risk
Evaluation.
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPPT-2016-0742, is available online
at https://www.regulations.gov or in-person at the Office of Pollution
Prevention and Toxics Docket (OPPT Docket), Environmental Protection
Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg.,
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC 20460-0001. The
Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is (202) 566-1744, and the telephone number for the OPPT
Docket is (202) 566-0280. Additional instructions on visiting the
docket, along with more information about dockets generally, is
available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Ingrid Feustel, Office of
Pollution Prevention and Toxics (7404M), Environmental Protection
Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone
number: (202) 564-3199; email address: [email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
[[Page 67902]]
I. General Information
A. Does this action apply to me?
This action is directed to the public in general and may be of
interest to those involved in the manufacture, processing,
distribution, use, disposal, and/or the assessment of risks involving
chemical substances and mixtures. You may be potentially affected by
this action if you manufacture (defined under TSCA to include import),
process (including recycling), distribute in commerce, use or dispose
of methylene chloride, including methylene chloride in products. Since
other entities may also be interested in this revision to the risk
determination, EPA has not attempted to describe all the specific
entities that may be affected by this action.
B. What is EPA's authority for taking this action?
TSCA section 6, 15 U.S.C. 2605, requires EPA to conduct risk
evaluations to determine whether a chemical substance presents an
unreasonable risk of injury to health or the environment, without
consideration of costs or other nonrisk factors, including an
unreasonable risk to a potentially exposed or susceptible subpopulation
(PESS) identified as relevant to the risk evaluation by the
Administrator, under the conditions of use. 15 U.S.C. 2605(b)(4)(A).
TSCA sections 6(b)(4)(A) through (H) enumerate the deadlines and
minimum requirements applicable to this process, including provisions
that provide instruction on chemical substances that must undergo
evaluation, the minimum components of a TSCA risk evaluation, and the
timelines for public comment and completion of the risk evaluation.
TSCA also requires that EPA operate in a manner that is consistent with
the best available science, make decisions based on the weight of the
scientific evidence, and consider reasonably available information. 15
U.S.C. 2625(h), (i), and (k).
The statute identifies the minimum components for all chemical
substance risk evaluations. For each risk evaluation, EPA must publish
a document that outlines the scope of the risk evaluation to be
conducted, which includes the hazards, exposures, conditions of use,
and the potentially exposed or susceptible subpopulations that EPA
expects to consider. 15 U.S.C. 2605(b)(4)(D). The statute further
provides that each risk evaluation must also: (1) integrate and assess
available information on hazards and exposures for the conditions of
use of the chemical substance, including information that is relevant
to specific risks of injury to health or the environment and
information on relevant potentially exposed or susceptible
subpopulations; (2) describe whether aggregate or sentinel exposures
were considered and the basis for that consideration; (3) take into
account, where relevant, the likely duration, intensity, frequency, and
number of exposures under the conditions of use; and (4) describe the
weight of the scientific evidence for the identified hazards and
exposures. 15 U.S.C. 2605(b)(4)(F)(i) through (ii) and (iv) through
(v). Each risk evaluation must not consider costs or other nonrisk
factors. 15 U.S.C. 2605(b)(4)(F)(iii).
EPA has inherent authority to reconsider previous decisions and to
revise, replace, or repeal a decision to the extent permitted by law
and supported by reasoned explanation. FCC v. Fox Television Stations,
Inc., 556 U.S. 502, 515 (2009); see also Motor Vehicle Mfrs. Ass'n v.
State Farm Mutual Auto. Ins. Co., 463 U.S. 29, 42 (1983).
C. What action is EPA taking?
EPA is announcing the availability of the final revision to the
risk determination for the methylene chloride risk evaluation issued
under TSCA that published in June 2020 (Ref. 1). In July 2022, EPA
sought public comment on the draft revisions (87 FR 39824, July 5,
2022). EPA appreciates the public comments received on the draft
revision to the methylene chloride risk determination. After review of
these comments and consideration of the specific circumstances of
methylene chloride, EPA concludes that the Agency's risk determination
for methylene chloride is better characterized as a whole chemical risk
determination rather than condition-of-use-specific risk
determinations. Accordingly, EPA is revising and replacing Section 5 of
the June 2020 Methylene Chloride Risk Evaluation (Ref. 2) where the
findings of unreasonable risk to health were previously made for the
individual conditions of use evaluated. EPA is also withdrawing the
previously issued TSCA section 6(i)(l) order for six conditions of use
previously determined not to present unreasonable risk which was
included in Section 5.4.1 of the June 2020 Methylene Chloride Risk
Evaluation (Ref. 2).
This final revision to the methylene chloride risk determination is
consistent with EPA's plans to revise specific aspects of the first ten
TSCA chemical risk evaluations to ensure that the risk evaluations
better align with TSCA's objective of protecting health and the
environment. As a result of this revision, removing the assumption that
workers always and appropriately wear PPE (see Unit II.C.) means that:
five additional conditions of use in addition to the original 47 drive
the unreasonable risk determination for methylene chloride; inhalation
risk to workers in addition to the previously identified inhalation
risk to occupational non-users (ONUs) drive the unreasonable risk in
three conditions of use; and additional risk to workers for acute and
chronic non-cancer dermal exposures and for cancer from inhalation
exposures also drive the unreasonable risk in many of those 52
conditions of use (where previously those conditions of use were
identified as presenting unreasonable risk only for chronic non-cancer
effects and/or acute effects). However, EPA is not making condition-of-
use-specific risk determinations for those conditions of use, and for
purposes of TSCA section 6(i), EPA is not issuing a final order under
TSCA section 6(i)(1) and does not consider the revised risk
determination to constitute a final agency action at this point in
time. Overall, 52 conditions of use out of 53 EPA evaluated drive the
methylene chloride whole chemical unreasonable risk determination due
to risks identified for human health. The full list of the conditions
of use evaluated for the methylene chloride TSCA risk evaluation is in
Tables 4-2 and 4-3 of the June 2020 Methylene Chloride Risk Evaluation
(Ref. 2).
II. Background
A. Why is EPA re-issuing the risk determination for the methylene
chloride risk evaluation conducted under TSCA?
In accordance with Executive Order 13990 (``Protecting Public
Health and the Environment and Restoring Science to Tackle the Climate
Crisis'') and other Administration priorities (Refs. 3, 4, 5, and 6),
EPA reviewed the risk evaluations for the first ten chemical
substances, including methylene chloride, to ensure that they meet the
requirements of TSCA, including conducting decision-making in a manner
that is consistent with the best available science.
As a result of this review, EPA announced plans to revise specific
aspects of the first ten risk evaluations in order to ensure that the
risk evaluations appropriately identify unreasonable risks and thereby
help ensure the protection of human health and the environment (Ref.
7). Following a review of specific aspects of the June 2020 Methylene
Chloride Risk Evaluation (Ref. 2) and after considering
[[Page 67903]]
comments received on a draft revised risk determination for methylene
chloride, EPA has determined that making an unreasonable risk
determination for methylene chloride as a whole chemical substance,
rather than making unreasonable risk determinations separately on each
individual condition of use evaluated in the risk evaluation, is the
most appropriate approach for methylene chloride under the statute and
implementing regulations. In addition, EPA's final risk determination
is explicit insofar as it does not rely on assumptions regarding the
use of PPE in making the unreasonable risk determination under TSCA
section 6, even though some facilities might be using PPE as one means
to reduce worker exposures; rather, the use of PPE as a means of
addressing unreasonable risk will be considered during risk management,
as appropriate.
Separately, EPA is conducting a screening approach to assess
potential risks from the air and water pathways for several of the
first 10 chemicals, including this chemical. For methylene chloride the
exposure pathways that were or could be regulated under another EPA
administered statute were excluded from the final risk evaluation (see
section 1.4.2 of the June 2020 Methylene Chloride Risk Evaluation).
This resulted in the surface water, drinking water and ambient air
pathways for methylene chloride not being assessed. The goal of the
recently-developed screening approach is to remedy this exclusion and
to identify if there may be risks that were unaccounted for in the
methylene chloride risk evaluation.
The screening-level approach has gone through public comment and
independent external peer review through the SACC. The Agency received
the final peer review report on May 18, 2022, and has reviewed public
comments and SACC comments. EPA expects to describe its views regarding
the chemical-specific application of this screening-level approach in
the forthcoming proposed rule under TSCA section 6(a) for methylene
chloride.
This action pertains only to the risk determination for methylene
chloride. While EPA intends to consider and may take additional similar
actions on other of the first ten chemicals, EPA is taking a chemical-
specific approach to reviewing these risk evaluations and is
incorporating new policy direction in a surgical manner, while being
mindful of Congressional direction on the need to complete risk
evaluations and move toward any associated risk management activities
in accordance with statutory deadlines.
B. What is a whole chemical view of the unreasonable risk determination
for the methylene chloride risk evaluation?
TSCA section 6 repeatedly refers to determining whether a chemical
substance presents unreasonable risk under its conditions of use.
Stakeholders have disagreed over whether a chemical substance should
receive: A single determination that is comprehensive for the chemical
substance after considering the conditions of use, referred to as a
whole-chemical determination; or multiple determinations, each of which
is specific to a condition of use, referred to as condition-of-use-
specific determinations.
As explained in the Federal Register document announcing the
availability of the draft revised risk determination for methylene
chloride (87 FR 39824, July 5, 2022 (FRL-9946-01-OCSPP)), the proposed
Risk Evaluation Procedural Rule (Ref. 8) was premised on the whole
chemical approach to making unreasonable risk determinations. In that
proposed rule, EPA acknowledged a lack of specificity in statutory text
that might lead to different views about whether the statute compelled
EPA's risk evaluations to address all conditions of use of a chemical
substance or whether EPA had discretion to evaluate some subset of
conditions of use (i.e., to scope out some manufacturing, processing,
distribution in commerce, use, or disposal activities), but also stated
that ``EPA believes the word `the' [in TSCA section 6(b)(4)(A)] is best
interpreted as calling for evaluation that considers all conditions of
use.'' The proposed rule, however, was unambiguous on the point that
unreasonable risk determinations would be for the chemical substance as
a whole, even if based on a subset of uses. See Ref. 8 at pages 7565-66
(``TSCA section 6(b)(4)(A) specifies that a risk evaluation must
determine whether `a chemical substance' presents an unreasonable risk
of injury to health or the environment `under the conditions of use.'
The evaluation is on the chemical substance--not individual conditions
of use--and it must be based on `the conditions of use.' In this
context, EPA believes the word `the' is best interpreted as calling for
evaluation that considers all conditions of use.''). In the proposed
regulatory text, EPA proposed to determine whether the chemical
substance presents an unreasonable risk of injury to health or the
environment under the conditions of use. (Ref. 8 at 7480.)
The final Risk Evaluation Procedural Rule stated (82 FR 33726, July
20, 2017 (FRL-9964-38)) (Ref. 9): ``As part of the risk evaluation, EPA
will determine whether the chemical substance presents an unreasonable
risk of injury to health or the environment under each condition of
uses [sic] within the scope of the risk evaluation, either in a single
decision document or in multiple decision documents'' (40 CFR 702.47).
For the unreasonable risk determinations in the first ten risk
evaluations, EPA applied this provision by making individual risk
determinations for each condition of use evaluated as part of each risk
evaluation document (i.e., the condition-of-use-specific approach to
risk determinations). That approach was based on one particular passage
in the preamble to the final Risk Evaluation Rule which stated that EPA
will make individual risk determinations for all conditions of use
identified in the scope. (Ref. 9 at 33744).
In contrast to this portion of the preamble of the final Risk
Evaluation Rule, the regulatory text itself and other statements in the
preamble reference a risk determination for the chemical substance
under its conditions of use, rather than separate risk determinations
for each of the conditions of use of a chemical substance. In the key
regulatory provision excerpted previously from 40 CFR 702.47, the text
explains that ``[a]s part of the risk evaluation, EPA will determine
whether the chemical substance presents an unreasonable risk of injury
to health or the environment under each condition of uses [sic] within
the scope of the risk evaluation, either in a single decision document
or in multiple decision documents'' (Ref. 9, emphasis added). Other
language reiterates this perspective. For example, 40 CFR 702.31(a)
states that the purpose of the rule is to establish the EPA process for
conducting a risk evaluation to determine whether a chemical substance
presents an unreasonable risk of injury to health or the environment as
required under TSCA section 6(b)(4)(B). Likewise, there are recurring
references to whether the chemical substance presents an unreasonable
risk in 40 CFR 702.41(a). See, for example, 40 CFR 702.41(a)(6), which
explains that the extent to which EPA will refine its evaluations for
one or more condition of use in any risk evaluation will vary as
necessary to determine whether a chemical substance presents an
unreasonable risk. Notwithstanding the one preambular statement about
condition-of-use-specific risk
[[Page 67904]]
determinations, the preamble to the final rule also contains support
for a risk determination on the chemical substance as a whole. In
discussing the identification of the conditions of use of a chemical
substance, the preamble notes that this task inevitably involves the
exercise of discretion on EPA's part, and ``as EPA interprets the
statute, the Agency is to exercise that discretion consistent with the
objective of conducting a technically sound, manageable evaluation to
determine whether a chemical substance--not just individual uses or
activities--presents an unreasonable risk'' (Ref. 9 at 33729).
Therefore, notwithstanding EPA's choice to issue condition-of-use-
specific risk determinations to date, EPA interprets its risk
evaluation regulation to also allow the Agency to issue whole-chemical
risk determinations. Either approach is permissible under the
regulation. A panel of the Ninth Circuit Court of Appeals also
recognized the ambiguity of the regulation on this point. Safer
Chemicals v. EPA, 943 F.3d. 397, 413 (9th Cir. 2019) (holding a
challenge about ``use-by-use risk evaluations [was] not justiciable
because it is not clear, due to the ambiguous text of the Risk
Evaluation Rule, whether the Agency will actually conduct risk
evaluations in the manner Petitioners fear'').
EPA plans to consider the appropriate approach for each chemical
substance risk evaluation on a case-by-case basis, taking into account
considerations relevant to the specific chemical substance in light of
the Agency's obligations under TSCA. The Agency expects that this case-
by-case approach will provide greater flexibility in the Agency's
ability to evaluate and manage unreasonable risk from individual
chemical substances. EPA believes this is a reasonable approach under
TSCA and the Agency's implementing regulations.
With regard to the specific circumstances of methylene chloride,
EPA has determined that a whole chemical approach is appropriate for
methylene chloride in order to protect health. The whole chemical
approach is appropriate for methylene chloride because there are
benchmark exceedances for a substantial number of conditions of use
(spanning across most aspects of the chemical lifecycle-from
manufacturing (including import), processing, industrial and commercial
use, consumer use, and disposal) for workers, occupational non-users,
consumers, and bystanders and irreversible health effects (specifically
cancer, coma, hypoxia, and death) associated with methylene chloride
exposures. Because these chemical-specific properties cut across the
conditions of use within the scope of the risk evaluation, a
substantial number of the conditions of use drive the unreasonable
risk; therefore, it is appropriate for the Agency to make a
determination for methylene chloride that the whole chemical presents
an unreasonable risk.
As explained later in this document, the revisions to the
unreasonable risk determination (Section 5 of the June 2020 Methylene
Chloride Risk Evaluation (Ref. 2)) follow the issuance of a draft
revision to the TSCA methylene chloride unreasonable risk determination
(87 FR 39824, July 5, 2022) and the receipt of public comment. A
response to comments document is also being issued with the final
revised unreasonable risk determination for methylene chloride (Ref.
10). The revisions to the unreasonable risk determination are based on
the existing risk characterization section of the June 2020 Methylene
Chloride Risk Evaluation (Ref. 2) (Section 4) and do not involve
additional technical or scientific analysis. The discussion of the
issues in this Federal Register document and in the accompanying final
revised risk determination for methylene chloride supersede any
conflicting statements in the June 2020 Methylene Chloride Risk
Evaluation (Ref. 2) and the earlier response to comments document (Ref.
11). EPA views the peer reviewed hazard and exposure assessments and
associated risk characterization as robust and upholding the standards
of best available science and weight of the scientific evidence per
TSCA sections 26(h) and (i).
For purposes of TSCA section 6(i), EPA is making a risk
determination on methylene chloride as a whole chemical. Under the
revised approach, the ``whole chemical'' risk determination for
methylene chloride supersedes the no unreasonable risk determinations
for methylene chloride that were premised on a condition-of-use-
specific approach to determining unreasonable risk and also contains an
order withdrawing the TSCA section 6(i)(1) order in Section 5.4.1 of
the June 2020 Methylene Chloride Risk Evaluation (Ref. 2).
C. What revision is EPA now making final about the use of PPE for the
methylene chloride risk evaluation?
In the risk evaluations for the first ten chemical substances, as
part of the unreasonable risk determination, EPA assumed for several
conditions of use that workers were provided and always used PPE in a
manner that achieves the stated assigned protection factor (APF) for
respiratory protection, or used impervious gloves for dermal
protection. In support of this assumption, EPA used reasonably
available information such as public comments indicating that some
employers, particularly in the industrial setting, provide PPE to their
employees and follow established worker protection standards (e.g.,
OSHA requirements for protection of workers).
For the June 2020 Methylene Chloride Risk Evaluation (Ref. 2), EPA
assumed, based on reasonably available information, including public
comment and safety data sheets for methylene chloride, that workers use
PPE--specifically respirators with an APF ranging from 25 to 50--for 26
occupational conditions of use and gloves with PF 10 or 20 for 39
occupational conditions of use. However, in the June 2020 Methylene
Chloride Risk Evaluation, EPA determined that there is unreasonable
risk to workers for 32 of those conditions of use.
EPA is revising the assumption for methylene chloride that workers
always and properly use PPE, although it does not question the public
comments received regarding the occupational safety practices often
followed by industry respondents. When characterizing the risk to human
health from occupational exposures during risk evaluation under TSCA,
EPA believes it is appropriate to evaluate the levels of risk present
in baseline scenarios where PPE is not assumed to be used by workers.
This approach of not assuming PPE use by workers considers the risk to
potentially exposed or susceptible subpopulations of workers who may
not be covered by OSHA standards, such as self-employed individuals and
public sector workers who are not covered by a State Plan. It should be
noted that, in some cases, baseline conditions may reflect certain
mitigation measures, such as engineering controls, in instances where
exposure estimates are based on monitoring data at facilities that have
engineering controls in place.
In addition, EPA believes it is appropriate to evaluate the levels
of risk present in scenarios considering applicable OSHA requirements
(e.g., chemical-specific permissible exposure limits (PELs) and/or
chemical-specific PELs with additional substance-specific standards),
as well as scenarios considering industry or sector best practices for
industrial hygiene that are clearly articulated to the Agency.
Consistent with this approach, the June 2020 Methylene Chloride Risk
[[Page 67905]]
Evaluation (Ref. 2) characterized risk to workers both with and without
the use of PPE. By characterizing risks using scenarios that reflect
different levels of mitigation, EPA risk evaluations can help inform
potential risk management actions by providing information that could
be used during risk management to tailor risk mitigation appropriately
to address any unreasonable risk identified, or to ensure that
applicable OSHA requirements or industry or sector best practices that
address the unreasonable risk are required for all potentially exposed
and susceptible subpopulations (including self-employed individuals and
public sector workers who are not covered by an OSHA State Plan).
When undertaking unreasonable risk determinations as part of TSCA
risk evaluations, however, EPA does not believe it is appropriate to
assume as a general matter that an applicable OSHA requirement or
industry practice related to PPE use is consistently and always
properly applied. Mitigation scenarios included in the EPA risk
evaluation (e.g., scenarios considering use of various PPE) likely
represent what is happening already in some facilities. However, the
Agency cannot assume that all facilities have adopted these practices
for the purposes of making the TSCA risk determination (Ref. 12).
Therefore, EPA is making a determination of unreasonable risk for
methylene chloride from a baseline scenario that does not assume
compliance with OSHA standards, including any applicable exposure
limits or requirements for use of respiratory protection or other PPE.
Making unreasonable risk determinations based on the baseline scenario
should not be viewed as an indication that EPA believes there are no
occupational safety protections in place at any location, or that there
is widespread non-compliance with applicable OSHA standards. Rather, it
reflects EPA's recognition that unreasonable risk may exist for
subpopulations of workers that may be highly exposed because they are
not covered by OSHA standards, such as self-employed individuals and
public sector workers who are not covered by a State Plan, or because
their employer is out of compliance with OSHA standards, or because
many of OSHA's chemical-specific permissible exposure limits largely
adopted in the 1970's are described by OSHA as being ``outdated and
inadequate for ensuring protection of worker health,'' (Ref. 13) or
because the OSHA Permissible Exposure Limit alone may be inadequate to
protect human health, or because EPA finds unreasonable risk for
purposes of TSCA notwithstanding OSHA requirements.
In accordance with this approach, EPA is finalizing the revision to
the methylene chloride risk determination without relying on
assumptions regarding the occupational use of PPE in making the
unreasonable risk determination under TSCA section 6; rather,
information on the use of PPE as a means of mitigating risk (including
public comments received from industry respondents about occupational
safety practices in use) will be considered during the risk management
phase, as appropriate. This represents a change from the approach taken
in the June 2020 Methylene Chloride Risk Evaluation (Ref. 2). As a
general matter, when undertaking risk management actions, EPA intends
to strive for consistency with applicable OSHA requirements and
industry best practices, including appropriate application of the
hierarchy of controls, to the extent that applying those measures would
address the identified unreasonable risk, including unreasonable risk
to potentially exposed or susceptible subpopulations. Consistent with
TSCA section 9(d), EPA will consult and coordinate TSCA activities with
OSHA and other relevant Federal agencies for the purpose of achieving
the maximum applicability of TSCA while avoiding the imposition of
duplicative requirements. Informed by the mitigation scenarios and
information gathered during the risk evaluation and risk management
process, the Agency might propose rules that require risk management
practices that may be already common practice in many or most
facilities. Adopting clear, comprehensive regulatory standards will
foster compliance across all facilities (ensuring a level playing
field) and assure protections for all affected workers, especially in
cases where current OSHA standards may not apply or be sufficient to
address the unreasonable risk.
Removing the assumption that workers always and appropriately wear
PPE in making the whole chemical risk determination for methylene
chloride means that: five conditions of use in addition to the original
47 conditions of use drive the unreasonable risk for methylene
chloride; an additional route of exposure (i.e., inhalation) is also
identified as driving the unreasonable risk to workers in three
conditions of use in addition to the previously identified inhalation
risk to occupational non-users; and additional risks to workers for
acute and chronic non-cancer dermal exposures and for cancer from
inhalation exposures also drive the unreasonable risk in many of those
52 conditions of use (where previously those conditions of use were
identified as presenting unreasonable risk only for chronic non-cancer
effects and/or acute effects). The finalized revision to the methylene
chloride risk determination clarifies that EPA does not rely on the
assumed use of PPE when making the risk determination for the whole
substance.
D. What is methylene chloride?
Methylene chloride, which is also called dichloromethane, is a
volatile chemical that is produced and imported into the United States,
with use estimated at over 260 million pounds per year. It is a solvent
used in a variety of industries and applications, such as adhesives,
paint and coating products, metal cleaning, chemical processing, and
aerosols. In addition, it is used as a propellent, processing aid, or
functional fluid in the manufacturing of other chemicals. A variety of
consumer and commercial products use methylene chloride as a solvent
including sealants, automotive products, and paint and coating
removers. Methylene chloride is subject to federal and state
regulations and reporting requirements.
E. What conclusions is EPA finalizing today in the revised TSCA risk
evaluation based on the whole chemical approach and not assuming the
use of PPE?
EPA determined that methylene chloride presents an unreasonable
risk to health under the conditions of use. EPA's unreasonable risk
determination for methylene chloride as a chemical substance is driven
by risks associated with the following conditions of use, considered
singularly or in combination with other exposures:
Manufacturing--Domestic manufacture;
Manufacturing--Import;
Processing into a formulation, mixture, or reaction
product;
Processing as a reactant;
Processing: recycling;
Repackaging;
Industrial and commercial use as solvent for batch vapor
degreasing;
Industrial and commercial use as solvent for in-line vapor
degreasing;
Industrial and commercial use as solvent for cold
cleaning; and commercial use as a solvent for aerosol spray degreasers/
cleaners;
Industrial and commercial use in adhesives, sealants, and
caulks;
Industrial and commercial use in paints and coatings;
Industrial and commercial use in paint and coating
removers;
[[Page 67906]]
Industrial and commercial use in adhesive and caulk
removers;
Industrial and commercial use as metal aerosol degreasers;
Industrial and commercial use in metal non-aerosol
degreasers;
Industrial and commercial use in finishing products for
fabric, textiles, and leather;
Industrial and commercial use in automotive care products
(functional fluids for air conditioners);
Industrial and commercial use in automotive care products
(interior car care);
Industrial and commercial use in automotive care products
(degreasers);
Industrial and commercial use in apparel and footwear care
products;
Industrial and commercial use in spot removers for apparel
and textiles;
Industrial and commercial use in liquid lubricants and
greases;
Industrial and commercial use in spray lubricants and
greases;
Industrial and commercial use in aerosol degreasers and
cleaners;
Industrial and commercial use in non-aerosol degreasers
and cleaners;
Industrial and commercial use in cold pipe insulations;
Industrial and commercial use as solvent that becomes part
of a formulation or mixture;
Industrial and commercial use as a processing aid;
Industrial and commercial use as propellant and blowing
agent;
Industrial and commercial use for electrical equipment,
appliance, and component manufacturing;
Industrial and commercial use for plastic and rubber
products manufacturing;
Industrial and commercial use for cellulose triacetate
film production;
Industrial and commercial use as anti-spatter welding
aerosol;
Industrial and commercial use for oil and gas drilling,
extraction, and support activities;
Industrial and commercial uses for toys, playgrounds, and
sporting equipments (including novelty articles);
Industrial and commercial use for carbon removers, wood
floor cleaners, and brush cleaners;
Industrial and commercial use as a lithographic printing
plate cleaner;
Industrial and commercial use as a laboratory chemical;
Consumer use as a solvent in an aerosol cleaner/degreaser;
Consumer use in adhesives and sealants;
Consumer use in paints and coatings (brush cleaners for
paints and coatings);
Consumer use in adhesives/caulk removers;
Consumer use in aerosol and non- aerosol metal degreasers;
Consumer use in automotive functional fluids (air
conditioners refrigerant, treatment, leak sealer);
Consumer use in automotive degreasers (gasket remover,
transmission cleaners, carburetor);
Consumer use in aerosol and non-aerosol lubricants and
greases, consumer use in cold pipe insulation;
Consumer use in aerosol and non-aerosol lubricants/greases
and aerosol and non-aerosol degreaser/cleaners;
Consumer use in cold pipe insulation;
Consumer use in crafting glue and cement/concrete;
Consumer use in anti-adhesive agent--anti-spatter welding
aerosol;
Consumer use in carbon remover and brush cleaner; and
Disposal.
The following condition of use does not drive EPA's unreasonable
risk determination for methylene chloride:
Distribution in commerce.
EPA is not making a condition of use-specific risk determination
for this condition of use, is not issuing a final order under TSCA
section 6(i)(1) for this condition of use, and does not consider the
revised risk determination for methylene chloride to constitute a final
agency action at this point in time.
Consistent with the statutory requirements of TSCA section 6(a),
EPA will propose a risk management regulatory action to the extent
necessary so that methylene chloride no longer presents an unreasonable
risk. EPA expects to focus its risk management action on the conditions
of use that drive the unreasonable risk. However, it should be noted
that, under TSCA section 6(a), EPA is not limited to regulating the
specific activities found to drive unreasonable risk and may select
from among a suite of risk management requirements in section 6(a)
related to manufacture (including import), processing, distribution in
commerce, commercial use, and disposal as part of its regulatory
options to address the unreasonable risk. As a general example, EPA may
regulate upstream activities (e.g., processing, distribution in
commerce) to address downstream activities (e.g., consumer uses)
driving unreasonable risk, even if the upstream activities do not drive
the unreasonable risk.
III. Summary of Public Comments
EPA received a total of 20 public comments on the July 5, 2022,
draft revised risk determination for methylene chloride during the
comment period that ended August 4, 2022, of which 19 were unique and
responsive to the request for comments. Commenters included trade
organizations, industry stakeholders, environmental groups, and non-
governmental health advocacy organizations. A separate document that
summarizes all comments submitted and EPA's responses to those comments
has been prepared and is available in the docket for this notice (Ref.
10).
IV. Revision of the June 2020 Methylene Chloride Risk Evaluation
A. Why is EPA revising the risk determination for the methylene
chloride risk evaluation?
EPA is finalizing the revised risk determination for the methylene
chloride risk evaluation pursuant to TSCA section 6(b) and consistent
with Executive Order 13990, (``Protecting Public Health and the
Environment and Restoring Science to Tackle the Climate Crisis'') and
other Administration priorities (Refs. 3, 4, 5, and 6). EPA is revising
specific aspects of the first ten TSCA existing chemical risk
evaluations in order to ensure that the risk evaluations better align
with TSCA's objective of protecting health and the environment. For the
methylene chloride risk evaluation, this includes: (1) Making the risk
determination in this instance based on the whole chemical substance
instead of by individual conditions of use and (2) Emphasizing that EPA
does not rely on the assumed use of PPE when making the risk
determination.
B. What are the revisions?
EPA is now finalizing the revised risk determination for the June
2020 Methylene Chloride Risk Evaluation (Ref. 2) pursuant to TSCA
section 6(b). Under the revised determination (Ref. 1), EPA concludes
that methylene chloride, as evaluated in the risk evaluation as a
whole, presents an unreasonable risk of injury to health when evaluated
under its conditions of use. This revision replaces the previous
unreasonable risk determinations made for methylene chloride by
individual conditions of use, supersedes the determinations (and
withdraws the associated order) of no unreasonable risk for the
conditions of use identified in the TSCA section 6(i)(1) no
unreasonable risk order, and clarifies the lack of reliance on assumed
use of PPE as part of the risk determination.
These revisions do not alter any of the underlying technical or
scientific information that informs the risk characterization, and as
such the hazard, exposure, and risk characterization sections are not
[[Page 67907]]
changed, except to statements about PPE assumptions in Section 2.4.1.1
(Consideration of Engineering Controls and PPE). The discussion of the
issues in this Notice and in the accompanying final revision to the
risk determination supersede any conflicting statements in the prior
executive summary, and Section 2.4.1.1 from the June 2020 Methylene
Chloride Risk Evaluation (Ref. 2) and the response to comments document
(Ref. 11).
The revised unreasonable risk determination for methylene chloride
includes additional explanation of how the risk evaluation
characterizes the applicable OSHA requirements, or industry or sector
best practices, and also clarifies that no additional analysis was
done, and the risk determination is based on the risk characterization
(Section 4) of the June 2020 Methylene Chloride Risk Evaluation (Ref.
2).
C. Will the revised risk determination be peer reviewed?
The risk determination (Section 5 of the June 2020 Methylene
Chloride Risk Evaluation (Ref. 2)) was not part of the scope of the
Science Advisory Committee on Chemicals (SACC) peer review of the
methylene chloride risk evaluation. Thus, consistent with that
approach, EPA did not conduct peer review of the final revised
unreasonable risk determination for the methylene chloride risk
evaluation because no technical or scientific changes were made to the
hazard or exposure assessments or the risk characterization.
V. Order Withdrawing Previous Order Regarding Unreasonable Risk
Determinations for Certain Conditions of Use
EPA is also issuing a new order to withdraw the TSCA Section
6(i)(1) no unreasonable risk order issued in Section 5.4.1 of the 2020
methylene chloride Risk Evaluation (Ref. 2). This final revised risk
determination supersedes the condition of use-specific no unreasonable
risk determinations in the June 2020 Methylene Chloride Risk Evaluation
(Ref. 2). The order contained in Section 5.5 of the revised risk
determination (Ref. 1) withdraws the TSCA section 6(i)(1) order
contained in Section 5.4.1 of the June 2020 Methylene Chloride Risk
Evaluation (Ref. 2). Consistent with the statutory requirements of
section 6(a), the Agency will propose risk management action to address
the unreasonable risk determined in the methylene chloride risk
evaluation.
VI. References
The following is a listing of the documents that are specifically
referenced in this document. The docket includes these documents and
other information considered by EPA, including documents that are
referenced within the documents that are included in the docket, even
if the referenced document is not physically located in the docket. For
assistance in locating these other documents, please consult the person
listed under FOR FURTHER INFORMATION CONTACT.
1. EPA. Unreasonable Risk Determination for Methylene Chloride.
October 2022.
2. EPA. Risk Evaluation for Methylene Chloride. June 2020. EPA
Document #740-R1-8010. https://www.regulations.gov/document/EPA-HQ-OPPT-2019-0437-0107.
3. Executive Order 13990. Protecting Public Health and the
Environment and Restoring Science to Tackle the Climate Crisis.
Federal Register (86 FR 7037, January 25, 2021).
4. Executive Order 13985. Advancing Racial Equity and Support for
Underserved Communities Through the Federal Government. Federal
Register (86 FR 7009, January 25, 2021).
5. Executive Order 14008. Tackling the Climate Crisis at Home and
Abroad. Federal Register (86 FR 7619, February 1, 2021).
6. Presidential Memorandum. Memorandum on Restoring Trust in
Government Through Scientific Integrity and Evidence-Based
Policymaking. Federal Register (86 FR 8845, February 10, 2021).
7. EPA. Press Release: EPA Announces Path Forward for TSCA Chemical
Risk Evaluations. June 2021. https://www.epa.gov/newsreleases/epa-announces-path-forward-tsca-chemical-risk-evaluations.
8. EPA. Proposed Rule; Procedures for Chemical Risk Evaluation Under
the Amended Toxic Substances Control Act. Federal Register (82 FR
7562, January 19, 2017) (FRL-9957-75).
9. EPA. Final Rule; Procedures for Chemical Risk Evaluation Under
the Amended Toxic Substances Control Act. Federal Register (82 FR
33726, 33744, July 20, 2017).
10. EPA. Response to Public Comments to the Revised Unreasonable
Risk Determination; Methylene Chloride (MC). October 2022.
11. EPA. Summary of External Peer Review and Public Comments and
Disposition for Methylene Chloride (MC). June 2020. Available at:
https://www.regulations.gov/document/EPA-HQ-OPPT-2019-0437-0083.
12. Occupational Safety and Health Administration (OSHA). Top 10
Most Frequently Cited Standards for Fiscal Year 2021 (Oct. 1, 2020,
to Sept. 30, 2021). Accessed October 13, 2022. https://www.osha.gov/top10citedstandards
13. OSHA. Permissible Exposure Limits--Annotated Tables. Accessed
June 13, 2022. https://www.osha.gov/annotated-pels.
Authority: 15 U.S.C. 2601 et seq.
Dated: November 4, 2022.
Michal Freedhoff,
Assistant Administrator, Office of Chemical Safety and Pollution
Prevention.
[FR Doc. 2022-24533 Filed 11-9-22; 8:45 am]
BILLING CODE 6560-50-P